2025 Q4 -tulosraportti
30 päivää sitten
‧13 min
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 5 379 | - | - | ||
| 10 000 | - | - | ||
| 6 739 | - | - | ||
| 5 000 | - | - | ||
| 17 061 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 7.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 12.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 12.5.2025 | ||
2024 Q4 -tulosraportti 13.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
18 t sitten18 t sittenMIB174 Listing: The CADScor system was included in a NICE (National Institute for Health and Care Excellence) Medtech Innovation Briefing (MIB174) in March 2019. Den 10.Marts 2026 var CADScor'en belyst i en artikel fra Oxford Acedemic, Louise . Bjerking mf.: "Journal Article Optimizing diagnostic resource use in suspected chronic coronary syndrome: pre-test probability and acoustic CAD rule-out in the FILTER-SCAD trial". Aims The FILTER-SCAD trial combined pre-test-probability (PTP) and the FDA-cleared coronary artery disease (CAD)-Score System to guide and improve deferred testing in suspected chronic coronary syndrome (CCS). However, adherence to the recommended strategy was low, with fewer than one-fourth of patients deferred. This study evaluates the potential of a PTP- and CAD-score-based deferral strategy on diagnostic resource consumption and clinical outcomes. Methods and results This observational post-hoc analysis included 1002 patients from the FILTER-SCAD intervention arm. Deferred testing was recommended for PTP ≤5% and/or CAD-score ≤20. We calculated the number of potentially deferred tests and clinical outcomes, including significant CAD and major adverse cardiac events (MACE). A deferred testing strategy could nearly double the number of safely deferred tests, reducing overall diagnostic test (n = 1043) volume by 275 tests (26%). Deferral based on PTP ≤5% alone would avoid unnecessary testing in 13.5% of patients, with an additional 31.3% deferrable based on CAD-score ≤20 (using the 2024 European Society of Cardiology risk factor-weighted likelihood increased deferral from 38.8% to 51.4%). Among the 135 low-likelihood patients (PTP ≤5%), 43.7% underwent testing, with only one (0.7%) positive test result, no invasive coronary angiographies, and no MACE. Among patients with CAD-score ≤20 tested (n = 209), 2.1% had positive test results, 1.9% were revascularized and there were two MACE. Conversely, 11.4% of the 596 higher likelihood patients (PTP >5%) were revascularized, and 20 patients experienced a MACE. Conclusion A strategy incorporating PTP and CAD-score can safely reduce unnecessary testing in low-likelihood CCS patients, optimizing resource use without compromising outcomes. Kilde: https://academic.oup.com/ehjdh/article/7/2/ztaf151/8416611- ·1 päivä sitten · MuokattuUSA: The RHTP initiative is seen as an opportunity to reduce unnecessary, expensive and invasive diagnostic procedures in rural areas, which is like a penalty kick against a drunk Russian. We are very close to a resolution, and since CMS already includes CADScor in their fixed reimbursement I see it as yet another plus. MENA: the war has probably scared some, but planes still deliver air freight to UAE etc. which is why this does not prevent the estimated 6.8 mill. SEK from being reached at the beginning of Q3. CEO has in the last 2-9 months confirmed that Kapacitet has multiplied the production of units and plastics several times over. Trend: We are with 0.2760 SEK up by 3% for the year. Number of owners in Nordnet: 1372, and thus only 4 persons from ath. Whether this indicates that a consolidation has occurred can be discussed, but everyone seems to hold and await the market value of the holding getting the deserved boost.
·9.3.LinkedIn profile for Jan Poulsen Quote from his page Acarix expands in the MENA region. As Chairman of the Board in Acarix, it is a pleasure to see how our footprint in the MENA region is expanding. This morning we announced that we have entered into a distribution agreement for Saudi Arabia. We believe that Saudi Arabia has the potential to become a significant market for us, and when we will be allowed to disclose the name of our partner, I am confident that it will become apparent that we are in competent hands. For a company like Acarix it is important to preserve ressources, both organizatorial and financial, so it is important to state, that the approval process is being led by our distributor and at their own expense. It is a bit unusual for us to disclose numbers, but in this case we have disclosed the qualified sales forcast for the 6 months immediately following approval, and with an estimated amount of SEK 9,8 million, this agreement alone will contribute significantly to our growth if executed to plan. This is all known. If one digs a little into who they have made an agreement with, it turns out to be. Al Faisaliah Medical Systems (FMS) It's incredibly good to have them on board Because they are one of the really big players in the Middle East that we've got our hands on. You can find information about them in several places, but here are the best sources to get an overview of their size and significance: 1. The official website (Tibbiyah) FMS is 100% owned by the listed company Tibbiyah (Arabian International Healthcare Holding Co.). Website: www.tibbiyah.com FMS is part of a gigantic family-owned conglomerate, founded in 1970 by the eldest son of the late King Faisal. Website: www.alfaisaliah.com They own everything from dairies (Al Safi Danone) to electronics (Sony distributor in Saudi) and healthcare. They are the ones with direct lines to the royals and the ministries. They collaborate with Philips FMS has a 50/50 Joint Venture with Philips Healthcare in Saudi Arabia. You can find info about this on Philips' official distributor pages for the Middle East. This means that when FMS launches CADScor, they do so with Philips backing them. That opens doors that no other distributors can open. FMS has over 50 years of experience and generates billions in revenue. They are not just a partner; they are the preferred partner for the Saudi Arabian Ministry of Health (NUPCO agreements).That Acarix has gotten FMS to pay for the local approvals and has received a forecast of SEK 9,8 million for the first 6 months, is a huge seal of approval. Large companies like FMS don't waste time on trifles unless they see enormous volume potential. So, that Acarix has gotten FMS to pay for the local approvals and has received a forecast of SEK 9,8 million for the first 6 months, is a huge seal of approval. Large companies like FMS don't waste time on trifles unless they see enormous volume potential. Well, I can't contain my excitement...·2 päivää sittenWhat I wrote in the beginning was also just a quote from him that he has stated previously, not meant to be understood as something new. I also write that it is a quote. It was more to inform that it is FMS they have agreements with, and what kind of entity they are. I just thought it was relevant info. Many are panicking these days, so it was just a bit of info. There are many things one doesn't quite catch in the big headlines, so when I have time, I like to dig a bit into what they are up to. I have had the stock for almost 5 years now and can just see which direction it's going. Amir and Co also need to deliver on what they are proposing, otherwise they have oversold the message. The stock market will also not send it north until we see the talk converted into cold hard cash. But I'm holding on..- ·4.3.Do you ever think that the stock will rise again to around the 15 SEK it once was?
·3 päivää sittenIt's not going well for Usa and Israel, Nethayahus brother killed, Ben Gvir injured/ bombed. Interceptor missiles are at 15% remaining. A special shipment of bombs has been sent from USA 150 million dollars. Israel wants to get Nato involved, so we should send what we have, it's not going well in the Middle East. The propaganda says otherwise, but even an American admiral, 3 generals have said that it will not end well. Nethanyahu is sitting in his private plane, is not in Israel... The stock market will turn upwards soon.. - ·3.3.I think Amir Mahmood will soon announce that he has bought again. He himself has mentioned that the stock is trading very low. The financial report has been released, so now he/they have a window and an opportunity to trade the stock, and also to announce that they are still involved. Vinhar long runway and the EU-MDR certification has not been utilized yet. If they break through to Germany, they will get the whole country in one go. And yes, it will probably take a little year, but one is long-term oriented :)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
30 päivää sitten
‧13 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- 18 t sitten18 t sittenMIB174 Listing: The CADScor system was included in a NICE (National Institute for Health and Care Excellence) Medtech Innovation Briefing (MIB174) in March 2019. Den 10.Marts 2026 var CADScor'en belyst i en artikel fra Oxford Acedemic, Louise . Bjerking mf.: "Journal Article Optimizing diagnostic resource use in suspected chronic coronary syndrome: pre-test probability and acoustic CAD rule-out in the FILTER-SCAD trial". Aims The FILTER-SCAD trial combined pre-test-probability (PTP) and the FDA-cleared coronary artery disease (CAD)-Score System to guide and improve deferred testing in suspected chronic coronary syndrome (CCS). However, adherence to the recommended strategy was low, with fewer than one-fourth of patients deferred. This study evaluates the potential of a PTP- and CAD-score-based deferral strategy on diagnostic resource consumption and clinical outcomes. Methods and results This observational post-hoc analysis included 1002 patients from the FILTER-SCAD intervention arm. Deferred testing was recommended for PTP ≤5% and/or CAD-score ≤20. We calculated the number of potentially deferred tests and clinical outcomes, including significant CAD and major adverse cardiac events (MACE). A deferred testing strategy could nearly double the number of safely deferred tests, reducing overall diagnostic test (n = 1043) volume by 275 tests (26%). Deferral based on PTP ≤5% alone would avoid unnecessary testing in 13.5% of patients, with an additional 31.3% deferrable based on CAD-score ≤20 (using the 2024 European Society of Cardiology risk factor-weighted likelihood increased deferral from 38.8% to 51.4%). Among the 135 low-likelihood patients (PTP ≤5%), 43.7% underwent testing, with only one (0.7%) positive test result, no invasive coronary angiographies, and no MACE. Among patients with CAD-score ≤20 tested (n = 209), 2.1% had positive test results, 1.9% were revascularized and there were two MACE. Conversely, 11.4% of the 596 higher likelihood patients (PTP >5%) were revascularized, and 20 patients experienced a MACE. Conclusion A strategy incorporating PTP and CAD-score can safely reduce unnecessary testing in low-likelihood CCS patients, optimizing resource use without compromising outcomes. Kilde: https://academic.oup.com/ehjdh/article/7/2/ztaf151/8416611
- ·1 päivä sitten · MuokattuUSA: The RHTP initiative is seen as an opportunity to reduce unnecessary, expensive and invasive diagnostic procedures in rural areas, which is like a penalty kick against a drunk Russian. We are very close to a resolution, and since CMS already includes CADScor in their fixed reimbursement I see it as yet another plus. MENA: the war has probably scared some, but planes still deliver air freight to UAE etc. which is why this does not prevent the estimated 6.8 mill. SEK from being reached at the beginning of Q3. CEO has in the last 2-9 months confirmed that Kapacitet has multiplied the production of units and plastics several times over. Trend: We are with 0.2760 SEK up by 3% for the year. Number of owners in Nordnet: 1372, and thus only 4 persons from ath. Whether this indicates that a consolidation has occurred can be discussed, but everyone seems to hold and await the market value of the holding getting the deserved boost.
- ·9.3.LinkedIn profile for Jan Poulsen Quote from his page Acarix expands in the MENA region. As Chairman of the Board in Acarix, it is a pleasure to see how our footprint in the MENA region is expanding. This morning we announced that we have entered into a distribution agreement for Saudi Arabia. We believe that Saudi Arabia has the potential to become a significant market for us, and when we will be allowed to disclose the name of our partner, I am confident that it will become apparent that we are in competent hands. For a company like Acarix it is important to preserve ressources, both organizatorial and financial, so it is important to state, that the approval process is being led by our distributor and at their own expense. It is a bit unusual for us to disclose numbers, but in this case we have disclosed the qualified sales forcast for the 6 months immediately following approval, and with an estimated amount of SEK 9,8 million, this agreement alone will contribute significantly to our growth if executed to plan. This is all known. If one digs a little into who they have made an agreement with, it turns out to be. Al Faisaliah Medical Systems (FMS) It's incredibly good to have them on board Because they are one of the really big players in the Middle East that we've got our hands on. You can find information about them in several places, but here are the best sources to get an overview of their size and significance: 1. The official website (Tibbiyah) FMS is 100% owned by the listed company Tibbiyah (Arabian International Healthcare Holding Co.). Website: www.tibbiyah.com FMS is part of a gigantic family-owned conglomerate, founded in 1970 by the eldest son of the late King Faisal. Website: www.alfaisaliah.com They own everything from dairies (Al Safi Danone) to electronics (Sony distributor in Saudi) and healthcare. They are the ones with direct lines to the royals and the ministries. They collaborate with Philips FMS has a 50/50 Joint Venture with Philips Healthcare in Saudi Arabia. You can find info about this on Philips' official distributor pages for the Middle East. This means that when FMS launches CADScor, they do so with Philips backing them. That opens doors that no other distributors can open. FMS has over 50 years of experience and generates billions in revenue. They are not just a partner; they are the preferred partner for the Saudi Arabian Ministry of Health (NUPCO agreements).That Acarix has gotten FMS to pay for the local approvals and has received a forecast of SEK 9,8 million for the first 6 months, is a huge seal of approval. Large companies like FMS don't waste time on trifles unless they see enormous volume potential. So, that Acarix has gotten FMS to pay for the local approvals and has received a forecast of SEK 9,8 million for the first 6 months, is a huge seal of approval. Large companies like FMS don't waste time on trifles unless they see enormous volume potential. Well, I can't contain my excitement...·2 päivää sittenWhat I wrote in the beginning was also just a quote from him that he has stated previously, not meant to be understood as something new. I also write that it is a quote. It was more to inform that it is FMS they have agreements with, and what kind of entity they are. I just thought it was relevant info. Many are panicking these days, so it was just a bit of info. There are many things one doesn't quite catch in the big headlines, so when I have time, I like to dig a bit into what they are up to. I have had the stock for almost 5 years now and can just see which direction it's going. Amir and Co also need to deliver on what they are proposing, otherwise they have oversold the message. The stock market will also not send it north until we see the talk converted into cold hard cash. But I'm holding on..
- ·4.3.Do you ever think that the stock will rise again to around the 15 SEK it once was?·3 päivää sittenIt's not going well for Usa and Israel, Nethayahus brother killed, Ben Gvir injured/ bombed. Interceptor missiles are at 15% remaining. A special shipment of bombs has been sent from USA 150 million dollars. Israel wants to get Nato involved, so we should send what we have, it's not going well in the Middle East. The propaganda says otherwise, but even an American admiral, 3 generals have said that it will not end well. Nethanyahu is sitting in his private plane, is not in Israel... The stock market will turn upwards soon..
- ·3.3.I think Amir Mahmood will soon announce that he has bought again. He himself has mentioned that the stock is trading very low. The financial report has been released, so now he/they have a window and an opportunity to trade the stock, and also to announce that they are still involved. Vinhar long runway and the EU-MDR certification has not been utilized yet. If they break through to Germany, they will get the whole country in one go. And yes, it will probably take a little year, but one is long-term oriented :)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 5 379 | - | - | ||
| 10 000 | - | - | ||
| 6 739 | - | - | ||
| 5 000 | - | - | ||
| 17 061 | - | - |
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 7.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 12.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 12.5.2025 | ||
2024 Q4 -tulosraportti 13.2.2025 |
2025 Q4 -tulosraportti
30 päivää sitten
‧13 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 7.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 12.2. | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 21.8.2025 | ||
2025 Q1 -tulosraportti 12.5.2025 | ||
2024 Q4 -tulosraportti 13.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- 18 t sitten18 t sittenMIB174 Listing: The CADScor system was included in a NICE (National Institute for Health and Care Excellence) Medtech Innovation Briefing (MIB174) in March 2019. Den 10.Marts 2026 var CADScor'en belyst i en artikel fra Oxford Acedemic, Louise . Bjerking mf.: "Journal Article Optimizing diagnostic resource use in suspected chronic coronary syndrome: pre-test probability and acoustic CAD rule-out in the FILTER-SCAD trial". Aims The FILTER-SCAD trial combined pre-test-probability (PTP) and the FDA-cleared coronary artery disease (CAD)-Score System to guide and improve deferred testing in suspected chronic coronary syndrome (CCS). However, adherence to the recommended strategy was low, with fewer than one-fourth of patients deferred. This study evaluates the potential of a PTP- and CAD-score-based deferral strategy on diagnostic resource consumption and clinical outcomes. Methods and results This observational post-hoc analysis included 1002 patients from the FILTER-SCAD intervention arm. Deferred testing was recommended for PTP ≤5% and/or CAD-score ≤20. We calculated the number of potentially deferred tests and clinical outcomes, including significant CAD and major adverse cardiac events (MACE). A deferred testing strategy could nearly double the number of safely deferred tests, reducing overall diagnostic test (n = 1043) volume by 275 tests (26%). Deferral based on PTP ≤5% alone would avoid unnecessary testing in 13.5% of patients, with an additional 31.3% deferrable based on CAD-score ≤20 (using the 2024 European Society of Cardiology risk factor-weighted likelihood increased deferral from 38.8% to 51.4%). Among the 135 low-likelihood patients (PTP ≤5%), 43.7% underwent testing, with only one (0.7%) positive test result, no invasive coronary angiographies, and no MACE. Among patients with CAD-score ≤20 tested (n = 209), 2.1% had positive test results, 1.9% were revascularized and there were two MACE. Conversely, 11.4% of the 596 higher likelihood patients (PTP >5%) were revascularized, and 20 patients experienced a MACE. Conclusion A strategy incorporating PTP and CAD-score can safely reduce unnecessary testing in low-likelihood CCS patients, optimizing resource use without compromising outcomes. Kilde: https://academic.oup.com/ehjdh/article/7/2/ztaf151/8416611
- ·1 päivä sitten · MuokattuUSA: The RHTP initiative is seen as an opportunity to reduce unnecessary, expensive and invasive diagnostic procedures in rural areas, which is like a penalty kick against a drunk Russian. We are very close to a resolution, and since CMS already includes CADScor in their fixed reimbursement I see it as yet another plus. MENA: the war has probably scared some, but planes still deliver air freight to UAE etc. which is why this does not prevent the estimated 6.8 mill. SEK from being reached at the beginning of Q3. CEO has in the last 2-9 months confirmed that Kapacitet has multiplied the production of units and plastics several times over. Trend: We are with 0.2760 SEK up by 3% for the year. Number of owners in Nordnet: 1372, and thus only 4 persons from ath. Whether this indicates that a consolidation has occurred can be discussed, but everyone seems to hold and await the market value of the holding getting the deserved boost.
- ·9.3.LinkedIn profile for Jan Poulsen Quote from his page Acarix expands in the MENA region. As Chairman of the Board in Acarix, it is a pleasure to see how our footprint in the MENA region is expanding. This morning we announced that we have entered into a distribution agreement for Saudi Arabia. We believe that Saudi Arabia has the potential to become a significant market for us, and when we will be allowed to disclose the name of our partner, I am confident that it will become apparent that we are in competent hands. For a company like Acarix it is important to preserve ressources, both organizatorial and financial, so it is important to state, that the approval process is being led by our distributor and at their own expense. It is a bit unusual for us to disclose numbers, but in this case we have disclosed the qualified sales forcast for the 6 months immediately following approval, and with an estimated amount of SEK 9,8 million, this agreement alone will contribute significantly to our growth if executed to plan. This is all known. If one digs a little into who they have made an agreement with, it turns out to be. Al Faisaliah Medical Systems (FMS) It's incredibly good to have them on board Because they are one of the really big players in the Middle East that we've got our hands on. You can find information about them in several places, but here are the best sources to get an overview of their size and significance: 1. The official website (Tibbiyah) FMS is 100% owned by the listed company Tibbiyah (Arabian International Healthcare Holding Co.). Website: www.tibbiyah.com FMS is part of a gigantic family-owned conglomerate, founded in 1970 by the eldest son of the late King Faisal. Website: www.alfaisaliah.com They own everything from dairies (Al Safi Danone) to electronics (Sony distributor in Saudi) and healthcare. They are the ones with direct lines to the royals and the ministries. They collaborate with Philips FMS has a 50/50 Joint Venture with Philips Healthcare in Saudi Arabia. You can find info about this on Philips' official distributor pages for the Middle East. This means that when FMS launches CADScor, they do so with Philips backing them. That opens doors that no other distributors can open. FMS has over 50 years of experience and generates billions in revenue. They are not just a partner; they are the preferred partner for the Saudi Arabian Ministry of Health (NUPCO agreements).That Acarix has gotten FMS to pay for the local approvals and has received a forecast of SEK 9,8 million for the first 6 months, is a huge seal of approval. Large companies like FMS don't waste time on trifles unless they see enormous volume potential. So, that Acarix has gotten FMS to pay for the local approvals and has received a forecast of SEK 9,8 million for the first 6 months, is a huge seal of approval. Large companies like FMS don't waste time on trifles unless they see enormous volume potential. Well, I can't contain my excitement...·2 päivää sittenWhat I wrote in the beginning was also just a quote from him that he has stated previously, not meant to be understood as something new. I also write that it is a quote. It was more to inform that it is FMS they have agreements with, and what kind of entity they are. I just thought it was relevant info. Many are panicking these days, so it was just a bit of info. There are many things one doesn't quite catch in the big headlines, so when I have time, I like to dig a bit into what they are up to. I have had the stock for almost 5 years now and can just see which direction it's going. Amir and Co also need to deliver on what they are proposing, otherwise they have oversold the message. The stock market will also not send it north until we see the talk converted into cold hard cash. But I'm holding on..
- ·4.3.Do you ever think that the stock will rise again to around the 15 SEK it once was?·3 päivää sittenIt's not going well for Usa and Israel, Nethayahus brother killed, Ben Gvir injured/ bombed. Interceptor missiles are at 15% remaining. A special shipment of bombs has been sent from USA 150 million dollars. Israel wants to get Nato involved, so we should send what we have, it's not going well in the Middle East. The propaganda says otherwise, but even an American admiral, 3 generals have said that it will not end well. Nethanyahu is sitting in his private plane, is not in Israel... The stock market will turn upwards soon..
- ·3.3.I think Amir Mahmood will soon announce that he has bought again. He himself has mentioned that the stock is trading very low. The financial report has been released, so now he/they have a window and an opportunity to trade the stock, and also to announce that they are still involved. Vinhar long runway and the EU-MDR certification has not been utilized yet. If they break through to Germany, they will get the whole country in one go. And yes, it will probably take a little year, but one is long-term oriented :)
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 5 379 | - | - | ||
| 10 000 | - | - | ||
| 6 739 | - | - | ||
| 5 000 | - | - | ||
| 17 061 | - | - |
Välittäjätilasto
Dataa ei löytynyt